(Q42489788)

1 November 2017

title

Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells (English)

1 reference

1 November 2017

6

1 reference

1 November 2017

7

1 reference

1 November 2017

Arianna Gonelli

5

0 references

Maria Grazia di Iasio

series ordinal

4

object named as

Maria Grazia di Iasio

1 reference

1 November 2017

3

Erika Rimondi

1 reference

1 November 2017

1

Federica Corallini

1 reference

1 November 2017

2

Claudio Celeghini

1 reference

1 November 2017

publication date

1 September 2011

1 reference

Journal of Cellular Physiology

1 November 2017

published in

1 reference

1 November 2017

volume

226

1 reference

1 November 2017

issue

9

1 reference

1 November 2017

page(s)

2279-2286

1 reference

Tumor inflammatory angiogenesis and its chemoprevention

1 November 2017

cites work

1 reference

The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases

21 January 2018

1 reference

OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer

21 January 2018

1 reference

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

21 January 2018

1 reference

Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer

21 January 2018

1 reference

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?

21 January 2018

1 reference

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases

21 January 2018

1 reference

Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels

21 January 2018

1 reference

Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells

21 January 2018

1 reference

Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

21 January 2018

1 reference

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis

21 January 2018

1 reference

Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.

21 January 2018

1 reference

The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival

21 January 2018

1 reference

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis

21 January 2018

1 reference

Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis

21 January 2018

1 reference

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.

21 January 2018

1 reference

Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells

21 January 2018

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1.

21 January 2018

1 reference

Differential susceptibility to TRAIL of normal versus malignant human urothelial cells.

21 January 2018

1 reference

Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1.

21 January 2018

1 reference

Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways

21 January 2018

1 reference

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

21 January 2018

1 reference

Role of full-length osteoprotegerin in tumor cell biology

21 January 2018

1 reference

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death

21 January 2018

1 reference

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.22564

1 reference

1 November 2017

1 reference